{"database": "openregs", "table": "documents", "rows": [["FDA-2005-D-0208-0003", "FDA", "FDA-2005-D-0208", "Guidance for Industry: Safety, Efficacy, and Pharmacokinetic Studies to Support Marketing of Immune Globulin Intravenous (Human) as Replacement Therapy for Primary Humoral Immunodeficiency; Availability", "Notice", "NAD-Notice of Availability of Data", "2008-07-17T04:00:00Z", 2008, 7, "2008-07-17T04:00:00Z", null, "2008-07-17T12:54:19Z", "E8-16395", 0, 0, "090000648067fb8d"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2005-D-0208-0003"], "units": {}, "query_ms": 0.6055530393496156, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}